1. Home
  2. CLDX vs ZGN Comparison

CLDX vs ZGN Comparison

Compare CLDX & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • ZGN
  • Stock Information
  • Founded
  • CLDX N/A
  • ZGN 1910
  • Country
  • CLDX United States
  • ZGN Italy
  • Employees
  • CLDX N/A
  • ZGN N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ZGN Apparel
  • Sector
  • CLDX Health Care
  • ZGN Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • ZGN Nasdaq
  • Market Cap
  • CLDX 1.9B
  • ZGN 2.1B
  • IPO Year
  • CLDX 2008
  • ZGN N/A
  • Fundamental
  • Price
  • CLDX $24.34
  • ZGN $10.42
  • Analyst Decision
  • CLDX Buy
  • ZGN Buy
  • Analyst Count
  • CLDX 10
  • ZGN 5
  • Target Price
  • CLDX $43.80
  • ZGN $10.22
  • AVG Volume (30 Days)
  • CLDX 866.0K
  • ZGN 604.9K
  • Earning Date
  • CLDX 11-10-2025
  • ZGN 09-05-2025
  • Dividend Yield
  • CLDX N/A
  • ZGN 1.34%
  • EPS Growth
  • CLDX N/A
  • ZGN N/A
  • EPS
  • CLDX N/A
  • ZGN 0.43
  • Revenue
  • CLDX $2,599,000.00
  • ZGN $2,248,050,499.00
  • Revenue This Year
  • CLDX N/A
  • ZGN N/A
  • Revenue Next Year
  • CLDX N/A
  • ZGN $4.55
  • P/E Ratio
  • CLDX N/A
  • ZGN $24.00
  • Revenue Growth
  • CLDX N/A
  • ZGN N/A
  • 52 Week Low
  • CLDX $14.40
  • ZGN $6.05
  • 52 Week High
  • CLDX $29.05
  • ZGN $10.70
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 44.59
  • ZGN 58.47
  • Support Level
  • CLDX $22.10
  • ZGN $9.59
  • Resistance Level
  • CLDX $26.85
  • ZGN $10.14
  • Average True Range (ATR)
  • CLDX 1.20
  • ZGN 0.27
  • MACD
  • CLDX -0.30
  • ZGN -0.04
  • Stochastic Oscillator
  • CLDX 36.70
  • ZGN 79.80

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About ZGN Ermenegildo Zegna N.V.

Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.

Share on Social Networks: